A Trojan horse transition state analogue generated by MgF3− formation in an enzyme active site
Identifying how enzymes stabilize high-energy species along the reaction pathway is central to explaining their enormous rate acceleration. β-Phosphoglucomutase catalyses the isomerization of β-glucose-1-phosphate to β-glucose-6-phosphate and appeared to be unique in its ability to stabilize a high-...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 103; no. 40; pp. 14732 - 14737 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Acad Sciences
03.10.2006
National Academy of Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Identifying how enzymes stabilize high-energy species along the reaction pathway is central to explaining their enormous rate acceleration. β-Phosphoglucomutase catalyses the isomerization of β-glucose-1-phosphate to β-glucose-6-phosphate and appeared to be unique in its ability to stabilize a high-energy pentacoordinate phosphorane intermediate sufficiently to be directly observable in the enzyme active site. Using 19 F-NMR and kinetic analysis, we report that the complex that forms is not the postulated high-energy reaction intermediate, but a deceptively similar transition state analogue in which MgF 3 − mimics the transferring PO 3 − moiety. Here we present a detailed characterization of the metal ion–fluoride complex bound to the enzyme active site in solution, which reveals the molecular mechanism for fluoride inhibition of β-phosphoglucomutase. This NMR methodology has a general application in identifying specific interactions between fluoride complexes and proteins and resolving structural assignments that are indistinguishable by x-ray crystallography. enzyme mechanism fluoride inhibition NMR structure phosphoryl transfer isosteric isoelectronic transition state analogue |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Perry A. Frey, University of Wisconsin, Madison, WI, and approved July 26, 2006 Author contributions: N.J.B., L.F.O., and M.G. contributed equally to this work; N.J.B., L.F.O., M.G., A.M.H., G.M.B., F.H., J.P.W., and N.H.W. designed research; N.J.B., L.F.O., M.G., A.M.H., W.B., J.P.W., and N.H.W. performed research; G.F. and W.B. contributed new reagents/analytic tools; N.J.B., L.F.O., M.G., F.H., J.P.W., and N.H.W. analyzed data; and N.J.B., L.F.O., M.G., G.M.B., F.H., J.P.W., and N.H.W. wrote the paper. Present address: Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0604448103 |